Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-25-042389
Filing Date
2025-09-23
Accepted
2025-09-22 20:40:22
Documents
16

Document Format Files

Seq Description Document Type Size
1 S-3 lifecorebiomedical-sx3.htm S-3 392927
2 lfcrfilingfees.htm   iXBRL EX-FILING FEES 40760
3 EX-5.1 exhibit51-sx3.htm EX-5.1 28362
4 EX-23.2 exhibit232-sx3.htm EX-23.2 2606
5 cover.jpg GRAPHIC 3344
6 lifecorelogo.jpg GRAPHIC 9260
  Complete submission text file 0001628280-25-042389.txt   641096

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT lfcrfilingfees_htm.xml XML 13082
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: S-3 | Act: 33 | File No.: 333-290460 | Film No.: 251331521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)